Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRKAR1B antisense RNA 1 (PRKAR1B-AS1) is a long noncoding RNA transcribed from the opposite strand of the PRKAR1B gene. As an antisense RNA, it may regulate the expression of its sense counterpart and potentially other genes through interactions at the RNA level. The full biological function and disease relevance of PRKAR1B-AS1 remain largely unexplored, in contrast to its paralog PRKAR1B-AS2, which is implicated in ovarian cancer and chemoresistance. There is currently no evidence supporting its direct role as a therapeutic target, nor are there known drugs or biomarkers associated with it[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRKAR1B antisense RNA 1 (PRKAR1B-AS1).